Lazard Asset Management’s Enfusion, Inc. ENFN Stock Holding History

Lazard Asset Management’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-255,690	Closed	-$2.85M	–	2578
2025 Q1	$2.85M	Buy	255,690 +121,355	+90%	+$1.34M	﹤0.01%	854
2024 Q4	$1.38M	Buy	134,335 +43,710	+48%	+$422K	﹤0.01%	1006
2024 Q3	$860K	Buy	90,625 +83,384	+1,152%	+$720K	﹤0.01%	1147
2024 Q2	$61K	Buy	+7,241	New	+$66.3K	﹤0.01%	1889
2023 Q2	–	Sell	-2,605	Closed	-$27K	–	2579
2023 Q1	$27K	Sell	2,605 -342	-12%	-$3.77K	﹤0.01%	1981
2022 Q4	$28K	Buy	+2,947	New	+$33.2K	﹤0.01%	2062

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lazard Asset Management's ENFN Position: Q2 2025 in Review

Lazard Asset Management sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 255,690 shares — an estimated $2.85M sold.

Lazard Asset Management first reported a position in ENFN in Q4 2022 and held it in 6 quarters. The position peaked at $2.85M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Lazard Asset Management reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Lazard Asset Management sold 255,690 Enfusion, Inc. shares in Q2 2025, an estimated $2.85M.
Lazard Asset Management first reported a position in Enfusion, Inc. in Q4 2022 and held it in 6 quarters.
Lazard Asset Management's Enfusion, Inc. position peaked at $2.85M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.